Helius Medical Technologies Inc HSDT

Healthcare Medical Devices

Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.

NDAQ:HSDT - Post by User

Helius Medical Technologies Inc

Bullboard Posts

Comment by miningfundion Sep 10, 2017 5:31pm

229 Views

Post# 26677556

RE:RE:Expect the good news in about 2.5 weeks

The share price decline over the past few weeks has been almost entirely attributable to one seller - Anonymous. SEDI does not report any recent insider selling - who is the seller?

The PoNS trial is expected to be completed by 09/30/17 - announcement shortly thereafter? Will this be a major price catalyst, or will it be the FDA approval expected H1 2018?

Is there any available financial analysis available that scopes the upside of a successful trial and FDA approval? To what extent has that upside already been built into the share price?

I don't have the answers, but I agree that now seems a good opportunity to pick up more shares.

Bullboard Posts

KWESST to provide situational awareness for the Canadian Red Cross